State of Wyoming’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,213
Closed -$59.6K 1877
2023
Q3
$59.6K Buy
+3,213
New +$36.3K 0.01% 1184
2023
Q1
Sell
-2,042
Closed -$25.3K 1825
2022
Q4
$25.3K Buy
+2,042
New +$28.9K 0.01% 1308
2022
Q3
Sell
-2,443
Closed -$34K 2051
2022
Q2
$34K Sell
2,443
-658
-21% -$10.5K 0.02% 1200
2022
Q1
$50K Buy
3,101
+1,072
+53% +$16.8K 0.03% 1058
2021
Q4
$33K Buy
+2,029
New +$34.2K 0.02% 1311

State of Wyoming's ICPT Position: Q4 2023 in Review

State of Wyoming sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 3,213 shares — an estimated $59.6K sold.

State of Wyoming first reported a position in ICPT in Q4 2021 and held it in 5 quarters. The position peaked at $59.6K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • State of Wyoming reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • State of Wyoming sold 3,213 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $59.6K.
  • State of Wyoming first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 5 quarters.
  • State of Wyoming's Intercept Pharmaceuticals, Inc. position peaked at $59.6K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on State of Wyoming's 13F filing for Q4 2023, filed 15 Feb 2024.